Novelix Pharmaceuticals Inc. Initiates Actinic Keratosis Drug Development Program Based on Topical Use of NVX-207 and Expands Intellectual Property Portfolio
12/2/2008 9:46:15 AM
More...
|
Novelix Pharmaceuticals Inc. Relocates to La Jolla, Expands Team and Closes Series A-3 Preferred Stock Financing
6/5/2008 9:12:02 AM
More...
|
Novelix Pharmaceuticals Inc. Announces Licensing of Cancer Compound to AOP Orphan Pharmaceuticals AG
2/26/2007 12:48:08 PM
More...
|